Training Future Scientists

The PhD program in clinical pharmaceutical sciences with a specialization in pharmacogenomics, prepares students for research careers in academia, industry or government. The focus is on genetic and non-genetic factors that contribute to individual response to drugs. This is a dynamic field with broad potential in present and future sciences.

Please link here for a complete overview of the PhD program , including application requirements, timeline for program completion and contact information.

Congratulations to the following students!

Post-doctoral fellow at the Center for Pharmacogenomics.

Center for Pharmacogenomics PhD Students

 Center for Pharmacogenomics PhD Candidates

Candidate	Photo
Elvin Price, Pharm.D. (Florida A & M University
Anzeela M. Schentrup, MS, Pharm.D. (University of Florida)

Fellowships

Cardiovascular-fellowship.pdf

2008 Summer Research Training Program

Pharmacy students at the University of Florida’s College of Pharmacy have a unique opportunity to participate in research that examines the role of pharmacogenomics in understanding individual drug metabolism based on genetic and non-genetic factors. Students will also have the opportunity to explore this fascinating area of pharmacological research as a career path and discover post-doctoral opportunities. Areas of research are:

• Asthma/Pulmonary Medicines and Diseases.
• Cardiovascular Diseases and Drug Therapy.
• Drug metabolism/Pharmacokinetic.
• Lipid Disorders.
• Diabetes and Metabolic Syndrome.

For further information on requirements, deadlines and contact information please go to:

http://plaza.ufl.edu/fryerf/DPP-SRTP.html

 Graduate Courses

Graduate Courses in Pharmacogenomics, Fall 2008

PHA 6449 Pharmacogenomics

Thursday s, 10:00 a.m – 12:00 p.m., Room PG-19

The course will use a combination of lectures, discussions of assigned literature, projects and student-led presentations to provide students with the knowledge and skills to undertake pharmacogenomics research.

Focus on pharmacogenetics/pharmacogenomics research design including,

• utilization of key knowledge from the human genome and HapMap projects
• candidate gene, versus genome-wide approaches
• other design considerations in pharmocogenomics investigations and candidate effects.

PHA 6427: Pharmacogenetics of Drug Metabolism and Transport (2): Examination of factors that affect drug disposition and response including genetics, as well as, additional factors such as environment, diet, age, and concurrent drug therapy and health status.  Students will acquire an understanding of pharmacogenetics/pharmacogenomics in the context of variability in drug disposition and the application of pharmacogenetics to drug development and drug treatment. Offered fall semester in even-numbered years.